Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stanford V vs ABVD in Advanced Hodgkin's Disease
NCT00041210Phase 3Unknown
- Sponsor
- Mount Vernon Cancer Centre
- Start
- Oct 2001
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mechlorethamine, vinblastine, doxorubicin, etoposide, vincristine in Hodgkin lymphoma (HL), sponsored by Mount Vernon Cancer Centre. Status: unknown.
02
Drugs
mechlorethaminevinblastinedoxorubicinetoposidevincristine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00041210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041210.